ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,309Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 3734

$1.28M Total Retail Price of All Prescriptions

Rank: 34 out of 3734

888 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 888 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 888 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 22,510 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 1,204 1,041 1 1
LEVOTHYROXINE SODIUM 910 861 2 2
LISINOPRIL 835 781 3 3
OMEPRAZOLE 703 557 4 4
FUROSEMIDE 641 600 5 7
AMLODIPINE BESYLATE 611 590 6 5
METOPROLOL TARTRATE 570 556 7 6
CITALOPRAM HBR 532 488 8 16
HYDROCODONE-ACETAMINOPHEN 503 451 S3 9 12
METFORMIN HCL 485 368 10 8
JANTOVEN 408 345 11 76
DONEPEZIL HCL 395 394 12 25
GABAPENTIN 367 334 13 17
ATENOLOL 357 309 14 13
GLIPIZIDE 347 319 15 57
NAMENDA 318 318 16 44
HYDROCHLOROTHIAZIDE 317 287 17 9
POTASSIUM CHLORIDE 316 293 18 19
SERTRALINE HCL 311 281 19 18
DIVALPROEX SODIUM 299 257 20 99
ATORVASTATIN CALCIUM 297 238 21 11
PANTOPRAZOLE SODIUM 267 229 22 22
CARVEDILOL 267 255 22 30
TRAMADOL HCL 264 236 24 20
LANTUS 259 257 25 54
CLOPIDOGREL 252 238 26 23
RISPERIDONE 242 219 27 62
TAMSULOSIN HCL 233 230 28 29
ALENDRONATE SODIUM 222 216 29 26
RANITIDINE HCL 222 173 29 32
PAROXETINE HCL 176 167 31 59
PLAVIX 176 164 31 39
DIOVAN 173 173 33 31
ADVAIR DISKUS 170 136 34 35
WARFARIN SODIUM 165 159 35 10
DIGOXIN 164 159 36 43
KLOR-CON M20 160 158 37 48
ISOSORBIDE MONONITRATE ER 158 152 38 34
GLIPIZIDE XL 153 114 39 85
TRAZODONE HCL 150 126 40 49
ETODOLAC 150 118 40 222
FENTANYL 139 139 S2 42 65
MORPHINE SULFATE 135 99 S2 43 220
POLYETHYLENE GLYCOL 3350 133 107 44 53
AGGRENOX 127 127 45 182
CELEBREX 127 104 45 69
ALBUTEROL SULFATE 125 117 47 128
PRAVASTATIN SODIUM 125 121 47 15
NYSTOP 124 111 49 187
ZETIA 124 115 49 55
QUETIAPINE FUMARATE 118 86 51 82
MIRTAZAPINE 117 114 52 45
BENICAR 116 116 53 107
METOPROLOL SUCCINATE 116 103 53 14
FAMOTIDINE 114 106 55 60
NEXIUM 112 108 56 36
AMLODIPINE BESYLATE-BENAZEPRIL 112 108 56 56
MELOXICAM 111 99 58 52
DETROL LA 109 109 59 153
CARBIDOPA-LEVODOPA 105 103 60 92
SPIRIVA 100 93 61 40
FINASTERIDE 98 94 62 88
DILTIAZEM 24HR ER 94 90 63 86
ACTOS 94 70 63 110
IBUPROFEN 94 86 63 75
BENICAR HCT 92 92 66 167
AZITHROMYCIN 90 70 67 38
FLUOXETINE HCL 89 59 68 61
PREDNISONE 89 84 68 42
VENTOLIN HFA 86 74 70 70
SEROQUEL 84 70 71 161
EXELON 84 84 71 150
OXYBUTYNIN CHLORIDE 84 74 71 151
PERMETHRIN 83 80 74 333
LEVOTHROID 82 66 75 359
LEVOFLOXACIN 79 69 76 116
COMBIVENT 75 74 77 156
SPIRONOLACTONE 72 55 78 80
NAPROXEN 70 62 79 101
GLIPIZIDE ER 70 70 79 119
ENALAPRIL MALEATE 70 54 79 63
NYSTATIN 69 69 82 162
TRIAMCINOLONE ACETONIDE 69 64 82 131
OLANZAPINE 69 43 82 106
KLOR-CON M10 67 61 85 115
LACTULOSE 67 67 85 137
TRICOR 66 66 87 93
CIPROFLOXACIN HCL 66 61 87 77
RISPERDAL CONSTA 64 40 89 330
SINGULAIR 64 58 89 95
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 58 91 117
ALLOPURINOL 62 62 92 33
PHENYTOIN SODIUM EXTENDED 62 56 92 149
LEVETIRACETAM 61 43 94 105
MECLIZINE HCL 61 57 94 139
NYAMYC 60 60 96 534
CARBAMAZEPINE 59 27 97 172
HYDRALAZINE HCL 59 59 97 111
ESCITALOPRAM OXALATE 59 50 97 68
PROAIR HFA 58 54 100 83
SYNTHROID 58 57 100 47
CLONIDINE HCL 57 40 102 79
INSULIN SYRINGE 57 51 102 109
TRAVATAN Z 56 56 104 278
LIPITOR 56 56 104 90
VENLAFAXINE HCL ER 56 40 104 84
FLUTICASONE PROPIONATE 55 49 107 46
METOCLOPRAMIDE HCL 55 51 107 158
FELODIPINE ER 55 55 107 132
BACLOFEN 55 0 107 142
TERAZOSIN HCL 55 55 107 136
NORTRIPTYLINE HCL 55 55 107 244
BUMETANIDE 54 54 113 78
DIVALPROEX SODIUM ER 53 34 114 198
BUSPIRONE HCL 52 20 115 129
CALCITONIN-SALMON 51 51 116 257
QUINAPRIL HCL 51 51 116 74
ZOLPIDEM TARTRATE 51 40 116 24
LYRICA 51 46 116 124
HUMALOG 51 46 116 146
CYMBALTA 50 39 121 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 12, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.